Biogen Inc. buy Royal Bank of Canada
Start price
02.05.25
/
50%
€109.15
Target price
02.05.26
€181.51
Performance (%)
29.87%
Price
16.01.26
€141.75
Summary
This prediction is currently active. The prediction currently has a performance of 29.87%. This prediction currently runs until 02.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -12.120% | -12.120% |
| iShares Core DAX® | 0.191% | 4.892% |
| iShares Nasdaq 100 | -0.614% | 2.901% |
| iShares Nikkei 225® | 0.599% | 7.404% |
| iShares S&P 500 | -0.036% | 3.489% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $217.00 to $205.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat